Researchers have carried out an in-depth analysis of 10,478 cancer genomes across 35 different cancer types, identifying 330 ...

For example, AI-powered tools are used to identify mutations in the BRCA1 and BRCA2 genes, which phenomenally raise the risk ...

Brisa Aschebrook-Kilfoy, Associate Professor of Family Medicine at UChicago, is an expert in conducting environmental exposure assessments. She is actively leading efforts to build resources to study ...

Oncologists caution that at-home genetic tests taken up by millions of Americans looking to gauge their cancer risk are not ...

A molar pregnancy, also known as a hydatidiform mole, is an abnormal human pregnancy with no embryo and an overgrowth of the ...

Two patients exceed 14 months on treatment in Phase 2 trial of advanced ovarian cancerAllarity maintains a cash balance of $18.5 million, ...

For example, people of eastern European Jewish descent are known to be at a high risk for BRCA1 and BRCA2 gene mutations that increase the risk for breast and ovarian cancers. If you learn that ...

Ovarian cancer vaccines are under development, but none are ready for primetime. There are no screening tools for ovarian ...

TOP1 is the target of topotecan, which was approved in 1997 by the U.S. Food and Drug Administration (FDA) to treat relapsed ...

Researchers worked with two labs to identify 16 consensus lower-risk pathogenic variants and are pushing for greater ...

By exploiting the genetic variation in cancer cells, an already approved cancer drug demonstrated enhanced effects against cancer cells in specific patient groups.

Lisa Bancroft is among thousands of people who have been tested for the faulty BRCA gene since its discovery 30 years ago.